Yoda Pharmaceuticals Inc. (TPEX:7829)

Yoda Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-364.07	-407.22	-192.19	-85.32	-43.85
Depreciation & Amortization	2.52	2.46	1.35	0.84	0.76
Stock-Based Compensation	39.73	39.73	-	0.5	-
Other Operating Activities	-0.39	-0.66	1.81	-2.35	0.01
Change in Accounts Receivable	0.7	2.1	1.25	0.06	-0.05
Change in Accounts Payable	4.63	12.93	-6.12	19.47	-1.27
Change in Other Net Operating Assets	1.44	-2.73	6.47	-9.91	0.15
Operating Cash Flow	-315.45	-353.39	-187.43	-76.71	-44.24
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Capital Expenditures	-0.52	-0.39	-2.32	-4.34	-
Investment in Securities	102.64	-614.27	242.22	-296.97	-
Other Investing Activities	-0.6	-0.69	-0.08	-	-0.01
Investing Cash Flow	101.52	-615.35	239.83	-301.3	-0.01

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Long-Term Debt Repaid	-	-0.79	-	-	-
Net Debt Issued (Repaid)	-0.8	-0.79	-	-	-
Issuance of Common Stock	920	728.01	465.66	0.02	-
Other Financing Activities	-	-	-	-	9.22
Financing Cash Flow	919.2	727.22	465.66	380.16	9.22

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Foreign Exchange Rate Adjustments	25.77	-2.21	16.28	13.42	2.34
Net Cash Flow	731.04	-243.73	534.34	15.57	-32.69

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Free Cash Flow	-315.97	-353.78	-189.75	-81.05	-44.24
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Per Share	-3.54	-4.47	-4.45	-6.81	-3.79
Levered Free Cash Flow	-187.81	-856.53	-139.28	-51.9	-
Unlevered Free Cash Flow	-187.8	-856.52	-139.28	-51.88	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash Interest Paid	0.03	0.03	-	0.04	-
Cash Income Tax Paid	-	-	-	1.09	0
Change in Working Capital	6.76	12.3	1.6	9.62	-1.17

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 18, 2026

Data Sources Report a data error